Folly, the first biotech-powered hair supplement, has announced its global launch, bringing a clinically potent hair gummy to market and addressing a longstanding issue in the supplement industry: underdosing and inconsistent delivery.
The launch coincides with a follow-on investment led by Khosla Ventures, which will support the global commercialisation of Folly’s microsphere encapsulation platform and expansion into new wellness categories.
The Problem: Weak Formulas and Inconsistent Delivery
Despite the popularity of hair supplements, many products fail to deliver meaningful results. Common issues include:
- Underdosing in gummies: Many hair gummies contain ingredients at levels too low to effectively support hair biology, rendering them little more than “vitamin candy.”
- Inconsistency with pills: Traditional pill-based protocols often require taking 3–4 large pills daily, which over half of women find difficult to maintain consistently.
As a result, patients frequently cycle through products that look promising but fail to deliver clinically relevant results or are too cumbersome to stay on long enough to see benefits.
The Folly Solution: Microsphere Technology
Folly’s breakthrough comes from applying drug-delivery science to hair supplements. Using Folly Microspheres™, a proprietary microencapsulation system, the supplement:
- Delivers 30+ clinically studied ingredients at levels comparable to pills and capsules (16× the dosage of the average gummy)
- Protects sensitive active ingredients during production and digestion
- Maintains high ingredient loading without compromising taste or daily usability
This approach ensures that nutrients reach the hair follicles effectively, rather than being degraded in the stomach.
Luna Yu, Co-Founder and CEO, explains:
“Folly was built to solve the supplement industry's delivery crisis: ensuring that clinically studied nutrients actually reach your follicles, not your stomach lining. I spent years working in pharmaceutical delivery science before realizing the supplement industry had never fully applied these principles. The same approaches that protect active ingredients in drug delivery can protect nutrients in a gummy. That is what Folly Microspheres do”.
Clinically Reported Results
In a 300-person consumer perception study, women using Folly daily for at least 30 days reported:
- 84% saw improved hair health
- 81% noticed fuller-looking hair
- 79% experienced less shedding
This demonstrates the potential for a highly effective, user-friendly hair supplement that delivers meaningful outcomes in just 30 days.
Launch Details
Folly will be available in April 2026 in the U.S. and U.K., with expansion planned across Europe and Asia later in the year.
For more information, visit: www.follynutrition.com or follow @FollyNutrition.
